The latest FDA drug approval for hepatitis C treatment is “a huge step forward,” says Dr. Paul Sax in
HIV and ID Observations.
On October 10, the FDA approved the first single-pill treatment for hepatitis C genotype 1, a tablet containing 400 mg of sofosbuvir and 90 mg of ledipasvir. In the latest HIV and ID Observations blog post, Dr. Paul Sax lists some of the reasons why this combination is instantly a treatment of choice.